Literature DB >> 10702689

Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome.

A Maho1, A Bensimon, G Vassart, M Parmentier.   

Abstract

Human CC-chemokine receptor genes are known to be clustered. The detailed structure of this cluster was established by radiation hybrid mapping, and organization of BAC contigs by fluorescence hybridization on combed genomic DNA. A main cluster of six genes (CCR1, CCR3, CCRL2, CCR5, CCR2 and CCXCR1), covered by four BACs, was mapped to the 3p21.3 region of the human genome. Five other genes (CCR9, CCBP2, CX3CR1, CCR8 and CCR4) were found to be spread over a relatively large region between this main cluster and the 3p telomere. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10702689     DOI: 10.1159/000015443

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  16 in total

1.  High frequency of the HIV-1 protective CCR5 delta32 deletion in native Estonians.

Authors:  I Kalev; A V Mikelsaar; L Beckman; G Tasa; P Pärlist
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.

Authors:  W B Breunis; M H Biezeveld; J Geissler; I M Kuipers; J Lam; J Ottenkamp; A Hutchinson; R Welch; S J Chanock; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

3.  Retrovirus vectors bearing jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3.

Authors:  S K Rai; J C DeMartini; A D Miller
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.

Authors:  Stuart J D Neil; Marlen M I Aasa-Chapman; Paul R Clapham; Robert J Nibbs; Aine McKnight; Robin A Weiss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.

Authors:  Thiago Hissnauer Leal Baltus; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Helena Kaminami Morimoto; Francieli Delongui; Daniela Frizon Alfieri; Tatiane Mayumi Veiga Iriyoda; Isaias Dichi; Andrea Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Rheumatol Int       Date:  2015-06-14       Impact factor: 2.631

Review 6.  The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2007-04       Impact factor: 2.332

7.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Inference of surface membrane factors of HIV-1 infection through functional interaction networks.

Authors:  Samira Jaeger; Gokhan Ertaylan; David van Dijk; Ulf Leser; Peter Sloot
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

9.  The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation.

Authors:  Gero Hütter; Martin Neumann; Daniel Nowak; Stefan Klein; Harald Klüter; Wolf-K Hofmann
Journal:  J Inflamm (Lond)       Date:  2011-10-26       Impact factor: 4.981

10.  Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.

Authors:  Alain Stepanian; Soraya Benchenni; Tiphaine Beillat-Lucas; Sophie Omnes; Fannie Defay; Edith Peynaud-Debayle; Gabriel Baron; Agnès Le Querrec; Michel Dreyfus; Laurence Salomon; Vassilis Tsatsaris; Dominique de Prost; Laurent Mandelbrot
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.